Jingyi Zhai

Also affiliated with Chinese PLA General Hospital, Shanxi Provincial Cancer Hospital, Shanxi Province Hospital of Traditional Chinese Medicine, Cancer Hospital of Chinese Academy of Medical Sciences

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target”.

A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target

Journal of Clinical Investigation(2020)10.1172/jci128672

N/A

0DataRank · unranked

137 citations

Thomas R. Nirschl, Daniel H. Hovelson, Robert J. Johnston, John Engelhardt, Mark Selby +15 more

Genetic Analysis of Sinonasal Undifferentiated Carcinoma Discovers Recurrent SWI/SNF Alterations and a novel PGAP3-SRPK1 Fusion Gene

Research Square(2020)10.21203/rs.3.rs-115402/v1

N/A

0DataRank · unranked

0 citations

Andrew C. Birkeland, Apurva D. Bhangale, Jingyi Zhai, Aditi Kulkarni, Susan K. Foltin +9 more

Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma

Oral Oncology(2021)10.1016/j.oraloncology.2021.105270

N/A

0DataRank · unranked

8 citations

Elizabeth Gensterblum‐Miller, Apurva D. Bhangale, Aditi Kulkarni, Jingyi Zhai, Joshua D. Smith +7 more

Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC

Cancers(2021)10.3390/cancers13194782

N/A

0DataRank · unranked

7 citations

Megan Ludwig, Aditi Kulkarni, Erin B. Scheftz, Isabel R. Murray, Jingyi Zhai +4 more

Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma

Head & Neck(2022)10.1002/hed.27018

N/A

0DataRank · unranked

10 citations

Megan Ludwig, Andrew C. Birkeland, Sai Nimmagadda, Jingyi Zhai, Jiayu Wang +13 more

Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma

Archives of Oral Biology(2023)10.1016/j.archoralbio.2023.105822

N/A

0DataRank · unranked

2 citations

Nicole L. Michmerhuizen, Jiayu Wang, Andrew C. Birkeland, Behirda Karaj Majchrowski, Sai Nimmagadda +7 more

Reconstruction of Single-Cell Trajectories Using Stochastic Tree Search

Genes(2023)10.3390/genes14020318

N/A

0DataRank · unranked

0 citations

Hongkai Ji, Hui Jiang, Jingyi Zhai

Challenges and advances of the stability of mRNA delivery therapeutics

Nucleic Acid Insights(2024)10.18609/nai.2024.015

N/A

0DataRank · unranked

19 citations

Timothy R. Coté, Y Chen, Jingyi Zhai

A Genome Wide CRISPR Profiling Approach Identifies Mechanisms of Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma

Research Square(2024)10.21203/rs.3.rs-3922565/v1

N/A

0DataRank · unranked

1 citations

Andrew C. Birkeland, Joshua D. Smith, Elizabeth Gensterblum‐Miller, Jingyi Zhai, Aditi Kulkarni +3 more

CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma

Head & Neck(2025)10.1002/hed.70048

N/A

0DataRank · unranked

0 citations

Megan Ludwig, Aditi Kulkarni, Andrew C. Birkeland, Nicole L. Michmerhuizen, Elizabeth Gensterblum‐Miller +9 more